HU-FIX Trial
Start date:2018 End date:
2020 Co-ordinated by:
Clare Moceivei Main trial site:
Royal Infirmary of Edinburgh
Assisting in identifying patients with Humeral shaft fractures in the ED by screening.
Giving patient information sheets to introduce the study, so patient has had adequate time to read and make decision about going into the trial before going to the fracture clinic.
Research Team
Rachel O'Brien
Lead Research Nurse
Julia Grahamslaw
Lead Research Nurse
Polly Black
Senior Research Nurse
Sian Dalgleish
Senior Research Nurse
Alison Williams
Senior Research Nurse
Fiona McCurrach
Senior Research Nurse
Caroline Blackstock
AMU Senior Research Nurse
More EMERGE Trials
The purpose of this study is to test a new vaccine, ChAdOx1 nCoV-19, against COVID-19 in healthy volunteers.
The ChAdOx1 nCoV-19 vaccine has been developed in Oxford in an effort to protect healthy people from the pandemic. This study will evaluate the safety of the vaccine and its ability to generate an immune response against the virus.
This is a randomised trial. Participants will be randomly allocated to receive either the ChAdOx1 nCoV-19 vaccine, or a Men ACWY (meningitus vaccine). Volunteers will not be told which vaccine they will receive.
Participants will be asked to return for 6 visits across 12 months to evaluate their health.
Across the UK the trial aims to recruit 10,260 volunteers.
If you are interested in taking part, please click on this link and complete the online questionnaire: https://www.covid19vaccinetrial.co.uk/participate-edinburgh
COV_002 Vaccine Trial
The purpose of this study is to test a new vaccine against COVID-19 in healthy volunteers.